PRICE T ROWE ASSOCIATES INC /MD/ - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2021$117,000
-38.1%
54,0950.0%0.00%
Q2 2021$189,000
-96.7%
54,095
-90.7%
0.00%
-100.0%
Q1 2021$5,708,000
-68.2%
578,926
-65.1%
0.00%
-50.0%
Q4 2020$17,967,000
+65.3%
1,657,433
+57.1%
0.00%
+100.0%
Q3 2020$10,868,000
-75.5%
1,055,133
-50.3%
0.00%
-83.3%
Q2 2020$44,363,000
+85.1%
2,124,648
-13.4%
0.01%
+50.0%
Q1 2020$23,969,000
+66.2%
2,453,366
+96.0%
0.00%
+100.0%
Q4 2019$14,421,000
+153.0%
1,251,787
+19.7%
0.00%
+100.0%
Q3 2019$5,701,000
-14.1%
1,046,102
+87.5%
0.00%0.0%
Q2 2019$6,635,000558,0360.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,043,212$46,578,00047.83%
Soleus Capital Management, L.P. 342,800$3,949,0003.81%
ACUTA CAPITAL PARTNERS, LLC 1,322,500$15,235,0003.77%
RTW INVESTMENTS, LP 6,386,607$73,574,0002.78%
Ghost Tree Capital, LLC 1,175,000$13,536,0002.58%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$5,530,0002.48%
VHCP Management III, LLC 946,234$10,901,0002.16%
Avoro Capital Advisors LLC 5,250,000$60,480,0001.78%
VHCP Management II, LLC 383,620$4,419,0001.16%
Rhenman & Partners Asset Management AB 650,000$7,488,0000.82%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders